Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect of Medinotec Inc. from 30 Sep 2021 to 31 May 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Medinotec Inc. quarterly and annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD history and change rate from 30 Sep 2021 to 31 May 2025.
  • Medinotec Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending 31 May 2025 was $818,809, a 183% decline year-over-year.
  • Medinotec Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2024 was $39,224, a 111% decline from 2023.
  • Medinotec Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2023 was $18,547, a 101% decline from 2022.
Source SEC data
View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Change (%)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Annual (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Annual Change (%)

Medinotec Inc. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $818,809 -$528,982 -183% 01 Mar 2025 31 May 2025 10-Q 16 Jul 2025 2026 Q1
Q2 2024 $289,827 -$172,579 -147% 01 Mar 2024 31 May 2024 10-Q 16 Jul 2025 2026 Q1
Q2 2023 $117,248 -$3,548,521 -103% 01 Mar 2023 31 May 2023 10-Q 12 Jul 2024 2025 Q1
Q3 2022 $538,924 -$537,515 -38149% 01 Jul 2022 30 Sep 2022 10-Q 17 Jan 2023 2023 Q3
Q2 2022 $3,431,273 01 Mar 2022 31 May 2022 10-Q 14 Jul 2023 2024 Q1
Q3 2021 $1,409 01 Jul 2021 30 Sep 2021 10-Q 17 Jan 2023 2023 Q3

Medinotec Inc. Annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $39,224 -$20,677 -111% 01 Mar 2024 28 Feb 2025 10-K 29 May 2025 2025 FY
2023 $18,547 -$2,714,427 -101% 01 Mar 2023 29 Feb 2024 10-K 29 May 2025 2025 FY
2022 $2,695,880 01 Mar 2022 28 Feb 2023 10-K 05 Jul 2024 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.